FDA product code QST: Lab-Based Hiv Nat Diagnostic And/Or Supplemental Test
QST is the FDA product code for lab-based hiv nat diagnostic and/or supplemental test. It is a Class II device, regulated under 21 CFR 866.3957 and reviewed by the Microbiology panel. Devices under QST reach the market by 510(k); FDA lists no cleared 510(k)s for it.
Definition
Human immunodeficiency virus (HIV) lab-based nucleic acid diagnostic and supplemental tests are prescription devices for the qualitative detection of HIV nucleic acid in human body fluids or tissues.
Classification
| Field | Value |
|---|---|
| Device name | Lab-Based Hiv Nat Diagnostic And/Or Supplemental Test |
| Device class | Class II |
| Regulation | 21 CFR 866.3957 |
| Review panel | MI — Microbiology |
| Medical specialty | Microbiology |
| Premarket route | 510(k) |
Recalls for QST devices
FDA recall records list no recalls for product code QST.
Frequently asked questions
What is FDA product code QST?
QST is the FDA product code for lab-based hiv nat diagnostic and/or supplemental test. It is a Class II device, regulated under 21 CFR 866.3957 and reviewed by the Microbiology panel.
What device class is QST?
Class II, regulation 21 CFR 866.3957. Typical premarket route: 510(k).
Next steps
- Run an FDA pathway report with predicate devices for product code QST
- Run a recall and safety report across every QST manufacturer
- Watch product code QST for new clearances and recalls
Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.
All Microbiology product codes · FDA product code lookup · 510(k) database search · 510(k) review times